Healthcare / Healthcare PlansUpdated 2026-05-10 22:07 UTC

ETR/CVS stock hub

ETR/CVS has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ETR/CVSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

98.2B

Deutsche Börse Xetra

Market data

Live price

Current market quote for this ticker.

Current price

ETR/CVS

In the news

Latest news · ETR/CVS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E11.9

P25 12.3P50 15.7P75 20.2

Trailing P/E38.6

P25 16.4P50 20.9P75 30.4

ROE3.8

P25 -6.7P50 8.5P75 17.2

ROIC6.3

P25 -1.7P50 8.5P75 17.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ETR/CVS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

232

Groups with data

Currency

USD

Showing 232 of 232 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	300,000
Employees Change	0%
Employees Change Percent	0
Enterprise value	EUR 154.8B
Exchange	Deutsche Börse Xetra
Financial currency	USD
First seen	2026-05-10
Industry	Healthcare Plans
Isin	US1266501006
Last refreshed	2026-05-10
Market cap	EUR 98.2B
Price	EUR 75.84
Price currency	EUR
Rev Per Employee	1,355,655.07x
Sector	Healthcare
Sic	8000
Symbol	etr/CVS
Website	https://www.cvshealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.59%
EV Earnings	60.89x
EV/EBIT	16.81x
EV/EBITDA	9.89x
EV/FCF	24.15x
EV/Sales	0.45x
FCF yield	6.53%
Forward P/E	11.86x
P/B ratio	1.46x
P/E ratio	38.6x
P/S ratio	0.28x
PE Ratio10 Y	23.11x
PE Ratio3 Y	36x
PE Ratio5 Y	30x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	2.67%
EBITDA Margin	3.8%
FCF margin	1.82%
Gross margin	13.39%
Gross Profit	EUR 47.1B
Gross Profit Growth	6.44%
Gross Profit Growth Q	8.46%
Gross Profit Growth3 Y	0.51%
Gross Profit Growth5 Y	2.25%
Net Income	EUR 2.5B
Net Income Growth	-44.47%
Net Income Growth Q	65.43%
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Net Income Growth3 Y	-10.52%
Net Income Growth5 Y	-16.89%
Pretax Margin	0.85%
Profit Margin	0.72%
Profit Per Employee	EUR 9,799
Profitable Years	7
ROA	2.67
Roa5y	3.25
ROCE	6.51
ROE	3.75
Roe5y	7.3
ROIC	6.3
Roic5y	6.76

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	34.58%
Cagr3y	9.73%
Cagr5y	5.09%
Div CAGR10	16.37%
Div CAGR3	0.95%
Div CAGR5	6.18%
EPS Growth	-45.23
EPS Growth Q	63.12
EPS Growth Quarters	2
EPS Growth Years	0
EPS Growth3 Y	-9.68
EPS Growth5 Y	-16.38
FCF Growth	24.46%
FCF Growth Q	-10.83%
FCF Growth3 Y	-24.81%
FCF Growth5 Y	-10.57%
OCF Growth	17.95%
OCF Growth Q	-6.74%
OCF Growth10 Y	1.54%
OCF Growth3 Y	-19.83%
OCF Growth5 Y	-7.73%
Revenue Growth	7.67x
Revenue Growth Q	6.15x
Revenue Growth Quarters	52x
Revenue Growth Years	15x
Revenue Growth3 Y	7.13x
Revenue Growth5 Y	8.47x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 1.6
Assets	EUR 219.4B
Cash	EUR 10.2B
Current Assets	EUR 63.4B
Current Liabilities	EUR 73.3B
Debt	EUR 67.9B
Debt EBITDA	EUR 4.25
Debt Equity	EUR 1.01
Debt FCF	EUR 10.6
Equity	EUR 67.3B
Interest Coverage	3.49
Liabilities	EUR 152.1B
Long Term Assets	EUR 156B
Long Term Liabilities	EUR 78.8B
Net Cash	EUR -57.7B
Net Cash By Market Cap	EUR -58.8
Net Debt EBITDA	EUR 4.32
Net Debt Equity	EUR 0.86
Net Debt FCF	EUR 9
Tangible Book Value	EUR -28.7B
Tangible Book Value Per Share	EUR -22.55

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.87
Inventory Turnover	19.99
Net Working Capital	EUR -16.4B
Quick ratio	0.61
Working Capital	EUR -10.1B
Working Capital Turnover	EUR -25.72

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.07%
Dividend Growth	-6.73%
Dividend Growth Years	0%
Dividend per share	EUR 2.28
Dividend Years	8
Dividend Yield	3%
Ex Div Date	2026-04-23
Last Dividend	EUR 0.57
Payout Frequency	Quarterly
Payout Ratio	116.1%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	34.56%
200-day SMA	65.11
3Y total return	32.14%
50-day SMA	66.26
50-day SMA vs 200-day SMA	50over200
5Y total return	28.14%
All Time High	105
All Time High Change	-27.8%
All Time High Date	2022-08-16
All Time Low	41.68
All Time Low Change	81.96%
All Time Low Date	2024-12-18
ATR	1.63
Ch YTD	11.38
High	75.84
High52	75.84
High52 Date	2026-05-08
High52ch	0%
Low	74.84
Low52	50.05
Low52 Date	2025-07-25
Low52ch	51.53%
Ma50ch	14.46%
Price vs 200-day SMA	16.48%
RSI	76.91
RSI Monthly	59.27
RSI Weekly	64.47
Sharpe ratio	0.94x
Sortino ratio	1.52
Total Return	1.93%
Tr YTD	13.27
Tr1m	13.3%
Tr1w	7.57%
Tr3m	15.63%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 9.4B
Operating Income Growth	16.19
Operating Income Growth Q	25.09
Operating Income Growth3 Y	-10.92
Operating Income Growth5 Y	-4.45
Operating margin	2.67

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,273,329,087%
Net Borrowing	-1,437,295,590
Shares Insiders	0.1%
Shares Institutions	89.95%
Shares Qo Q	0.16%
Shares Yo Y	1.07%
Short Ratio	2.31

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 5.8B
Average Volume	396.8x
Bv Per Share	52.77
CAPEX	EUR -2.5B
Ch1m	12.32
Ch1w	7.57
Ch1y	29.84
Ch3m	14.63
Ch3y	17.62
Ch5y	8.59
Ch6m	11.78
Change	2.76%
Change From Open	1.34
Close	73.8
Days Gap	1.41
Depreciation Amortization	3,872,642,454
Dollar Volume	7,963.2
Earnings Date	2026-08-05
EBIT	EUR 9.4B
EBITDA	EUR 13.4B
EPS	EUR 1.99
F Score	6
FCF	EUR 6.4B
FCF EV Yield	4.14x
Financing CF	-4,272,319,800
Fiscal Year End	December
Founded	1,963
Goodwill	72,482,095,836
Graham Number	47.95638
Graham Upside	-36.77
Income Tax	EUR 480.5M
Investing CF	-5,189,055,900
Is Primary Listing	0
Last Earnings Date	2026-02-04
Last Report Date	2026-03-31
Lynch Fair Value	EUR 9.82
Lynch Upside	-87.05
Ma150	66.94
Ma150ch	13.29%
Ma20	68.01
Ma20ch	11.51%
Net CF	-500,432,100
Next Earnings Date	2026-08-05
Open	74.84
P FCF Ratio	15.31
P OCF Ratio	10.95
Payment Date	2026-05-04
Position In Range	100
Ppne	23,554,688,436
Price Date	2026-05-08
Price EBITDA	EUR 7.34
Relative Volume	0.27x
Revenue	351,792,491,400x
SBC By Revenue	0.17x
Share Based Comp	585,427,500
Tax By Revenue	0.14x
Tax Rate	16.03%
Tr6m	13.67%
Volume	105
Z Score	2.35

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

ETR/CVS dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.0%

$2.28 annual per share

Payout ratio

+116.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+6.2%

0 consecutive years of growth

Total shareholder yield

+1.9%

Next ex-dividend date: 2026-04-23

Performance

ETR/CVS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ETR/CVS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+90.0%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

ETR/CVS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

76.9

Above 70: short-term overbought

Price vs 200-day MA

+16.5%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.94

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ETR/CVS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/CVS stock rating?

etr/CVS is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/CVS analysis?

The full report lives at /stocks/etr/CVS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/CVS?

The latest report frames etr/CVS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/CVS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.